A research team from the Institute of Medical Microbiology, University of Münster, Germany, has developed a method that accelerates resistance testing. In cooperation with an industrial partner, this innovative method can now be optimized for the diagnostic market.
Respiratory, urinary tract, wound infections, and sepsis: the list of sites in which severe and life-threatening diseases manifest as a result of multidrug resistant microorganisms is long. The best option is an antibiotic treatment targeted specifically to the detected pathogen. However, the identification of microorganisms and their resistances to antibiotics is time consuming.
Symbolic picture: Application of microdroplets for rapid determination of resistance using MALDI-TOF mass spectrometry
photo: FZ / E. Deiters-Keul
A research team from the Institute of Medical Microbiology, University of Münster, Germany, has developed a method that considerably accelerates resistance testing. Supported by the German Federal Ministry of Education and Research (BMBF), and in cooperation with an industrial partner, the research team is currently developing this method. Soon to be on the market, it will be readily available for patient management.
The novel method proposed by project leaders Evgeny A. Idelevich, M.D. and Karsten Becker, M.D. is based on MALDI-TOF mass spectrometry, which was recently introduced for microbial identification. Prof. Becker observed, “We also need new techniques for more expedient detection of acquired antibiotic resistance”.
Currently applied methods require more than 24 hours, as they are dependent on bacterial growth. The innovative method from Münster would allow earlier optimization of patient treatment and the prompt initiation of infection control measures, crucial for the protection of hospital patients from a spread of multidrug resistant bacteria.
Currently, many physicians administer broad-spectrum antibiotics to swiftly provide a reliable medicine. Unfortunately, microorganisms can become resistant due to this very treatment. The shift to a more targeted antibiotic therapy reduces antibiotic selection pressure and thus, the emergence of multiresistant bacteria.
Dr. Idelevich added, “The application of MALDI-TOF mass spectrometry for resistance testing was attractive to our research due to its expediency and high accuracy. It can also be optimally combined with the identification process, rendering it cost-efficient”.
Based on this technology, both researchers have developed a rapid and universal method for resistance determination which is independent from the underlying resistance mechanisms and can be performed simultaneously for multiple antibiotics. Through the license agreement with Bruker Daltonik (Bremen, Germany), a pioneer in mass spectrometry technologies, this innovative method can now be developed further and optimized for the diagnostic market.
Prof. Becker commented, “We hope that our method will be available for routine use in clinical laboratories in 2-3 years”. Here in Münster, we are particularly proud of the MALDI-TOF mass spectrometry project, as the MALDI-TOF technology was greatly influenced in the 1980s by Münster scientists. At that time, the groundwork was established for today’s microbial identification. Currently, thousands of laboratories worldwide already use a MALDI-TOF instrument. This sets optimal preconditions for the wide-spread and cost-efficient implementation of our method.”
The cooperation between academic and industrial institutions in Münster and Bremen will be supported by the BMBF for an additional three years; a grant totaling more than 900,000 Euros was awarded to the academic and industrial partners.
Dr. Thomas Bauer
Referent Research and Teaching at Münster University Medical Faculty
Dr. Thomas Bauer | idw - Informationsdienst Wissenschaft
Purdue cancer identity technology makes it easier to find a tumor's 'address'
16.11.2018 | Purdue University
Microgel powder fights infection and helps wounds heal
14.11.2018 | Michigan Technological University
Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.
Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...
Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.
Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...
Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.
In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...
On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.
When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure
Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...
09.11.2018 | Event News
06.11.2018 | Event News
23.10.2018 | Event News
16.11.2018 | Health and Medicine
16.11.2018 | Life Sciences
16.11.2018 | Life Sciences